Akebia Ther share price logo

Akebia Ther

NASDAQ: AKBA

Small Cap

$1.48

+0.08

(+5.71%)

Live

as on

Akebia Ther Stock Performance

as on May 5, 2026 at 1:06 am IST

  • Day's Low

    Day's High

    $1.41
    $1.49
    downward going graph

    4.73%

    Downside

    0.68%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.14
    $4.08
    downward going graph

    22.97%

    Downside

    175.59%

    Upside

    downward going graph

Akebia Ther share price movements today

Previous Close
$1.40
Open
$1.42
Volume
775.6K
Day's Low - High
$1.41 - $1.49
52 Week Low - High
$1.14 - $4.08

Akebia Ther Historical Returns

1 Month Return
+ 1.45 %
3 Month Return
+ 2.19 %
1 Year Return
-42.86 %
3 Year Return
+ 50.57 %
5 Year Return
-52.7 %

Akebia Ther Stock Fundamentals & Key Indicators

Check Akebia Ther market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$375.6M

EPS (TTM)

-0.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

27.3M

Revenue (TTM)

236.2M

Profit Margin

-2.26%

Return On Equity TTM

-553.45%

Akebia Ther vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Akebia Ther with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Akebia Ther image
Akebia Ther
BUY$375.6M-52.7%NA-2.26%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$24.2BNA20.4941.94%
Viatris Inc image
Viatris Inc
HOLD$17.5B12.24%NA-24.58%
Haleon plc image
Haleon plc
BUY$41.7BNA18.7615.11%
Zoetis Inc image
Zoetis Inc
BUY$48.2B-34.3%18.9628.24%

Stock Returns calculator for Akebia Ther Stock including INR - Dollar returns

The Akebia Ther stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Akebia Ther investment value today

Current value as on today

₹68,128

Returns

-₹31,872

(-31.87%)

Returns from Akebia Ther Stock

-₹39,592 (-39.59%)

Dollar Impact

₹7,720 (+7.72%)

Analyst Recommendation on Akebia Ther Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Akebia Ther. Average target price of $4.4

Akebia Ther Share Price Target

Get share price movements and forecasts by analysts on Akebia Ther.

What analysts predicted

66.36%UPSIDE

Target Price

$4.4

Current Price

$1.48

Analyzed by

9 Analysts

Target

$4.40

Akebia Ther target price $4.4, a slight upside of 66.36% compared to current price of $1.48. According to 9 analysts rating.

Akebia Ther Stock’s Investor Sentiment and Interest

Search interest for Akebia Ther Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-20% versus previous 30 day period

Akebia Ther Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
42
56
32
43
37
46
57
62
58
57
Gross Profit
24
37
29
35
23
26
49
52
49
45
Operating Income
-13
1
-14
-8
-12
-14
13
14
4
-8
EBITDA
-3
11
-4
1
-4
-6
14
7
6
-6
Interest Expense
1
1
2
2
6
6
7
6
4
4
Depreciation
9
14
9
9
9
9
0
0
0
0
Income Before Tax
-14
0
-17
-8
-20
-22
6
0
1
-11
Income Tax Expense
1
0
9
-
-
-
-
-
0
1
Net Income
-14
0
-17
-8
-20
-22
6
0
0
-12
Net Profit Margin
-34.46%
1.09%
-55.16%
-19.66%
-53.54%
-49.04%
10.66%
0.40%
0.92%
-21.25%

Akebia Ther Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
177
207
335
295
213
292
194
160
236
Gross Profit
-114
177
200
189
0
60
269
120
97
196
Operating Income
-136
-79
-178
-286
-376
-265
-80
-46
-50
23
EBITDA
-136
-76
-175
-247
-342
-227
3
-8
-13
21
Interest Expense
0
2
6
38
8
19
15
6
18
24
Depreciation
-
0
2
38
33
37
37
37
37
1
Income Before Tax
-135
-76
-171
-286
-383
-282
-94
-51
-69
-3
Income Tax Expense
0
-2
-28
-6
-33
-37
13
41
-
1
Net Income
-135
-76
-171
-279
-349
-244
-94
-51
-69
-5
Net Profit Margin
-8843.45%
-43.21%
-82.75%
-83.48%
-118.48%
-114.65%
-32.22%
-26.68%
-43.33%
-2.26%

Akebia Ther Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
0
-17
-8
-20
-22
6
0
0
-12
Operating Cash Flow
-2
-19
-10
-6
-4
-13
22
28
31
Investing Cash Flow
-
-
0
0
0
0
0
0
-7
Financing Cash Flow
-1
18
7
1
22
74
1
1
-4
Change in Cash
-3
0
-2
-5
17
61
23
29
18

Akebia Ther Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-76
-143
-279
-383
-282
-92
-51
-69
-5
Operating Cash Flow
-56
-97
-257
-110
-252
-73
-23
-40
67
Investing Cash Flow
-177
36
211
-40
39
0
-
0
-7
Financing Cash Flow
116
96
88
231
133
14
-25
49
72
Change in Cash
-117
35
42
81
-79
-58
-48
8
132

Global Institutional Holdings in Akebia Ther

Funds
Holdings
State Street Corp
4.42%
Great Point Partners LLC
0.75%
Geode Capital Management, LLC
2.34%
Renaissance Technologies Corp
1.34%
UBS Group AG
1.36%
See all

Akebia Ther News & Key Events

    Insights on Akebia Ther

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, United Therapeutics Corporation has given 93.6% return, outperforming this stock by 136.5%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, United Therapeutics Corporation has given 164.4% return, outperforming this stock by 113.8%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, 540.0K → -12.24M (in $), with an average decrease of 2367.4% per quarter

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 3 quarters, 62.47M → 57.62M (in $), with an average decrease of 3.9% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 6 months, AKBA stock has moved down by -33.0%

    About Akebia Ther

    Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent (DD) and non-dialysis dependent (NDD) patients; and Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD and the treatment of iron deficiency anemia in adult patients with NDD-CKD. The company is also developing AKB-9090, which is in Phase 2 clinical trial for treating cardiac surgery-related acute kidney injury and acute respiratory distress syndrome; and AKB-10108 for the treatment of retinopathy of prematurity in neonates. The company has license and collaboration agreements with Tanabe Pharma Corporation for the development and commercialization of Vafseo in Japan and other Asian countries; Vafseo License and Collaboration Agreements; CSL Vifor Agreements; Averoa License Agreement; License Agreement with Panion & BF Biotech, Inc.; Cyclerion Therapeutics License Agreement; and Q32 Asset Purchase Agreement. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
    OrganisationAkebia Ther
    Headquarters245 First Street, Cambridge, MA, United States, 02142
    IndustryDrug Manufacturers - Specialty & Generic
    CEOMr. John P. Butler MBA
    E-voting on sharesClick here to vote

    Key Management of Akebia Ther

    Name

    Title

    Dr. Steven Keith Burke M.D.

    Senior VP and Chief Research & Development Officer

    Mercedes Carrasco

    Senior Director of Investor & Corporate Communications

    Ms. Carolyn M. Rucci

    Senior VP, Chief Legal Officer & Secretary

    Dr. Justin McCue Ph.D.

    Senior VP & Chief Technology Officer

    Ms. Meredith Bowman

    Senior VP & Chief People Officer

    Mr. John P. Butler MBA

    CEO, President & Director

    Mr. Erik John Ostrowski M.B.A.

    Chief Business Officer, Senior VP, CFO & Treasurer

    Mr. Nicholas Grund

    Senior VP & Chief Commercial Officer

    Mr. Richard C. Malabre

    Senior VP & Chief Accounting Officer

    FAQs

    What is Akebia Ther share price today?

    Akebia Ther share price today is $1.48 as on . Akebia Ther share today touched a day high of $1.49 and a low of $1.41.

    What is the 52 week high and 52 week low for Akebia Ther share?

    Akebia Ther share touched a 52 week high of $4.08 on and a 52 week low of $1.14 on . Akebia Ther stock price today i.e. is trending at $1.48,which is 63.71% down from its 52 week high and 29.82% up from its 52 week low.

    What is Akebia Ther's market capitalisation today?

    Akebia Ther market capitalisation is $0.00T as on .

    How to invest in Akebia Ther Stock (AKBA) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Akebia Ther on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Akebia Ther Shares that will get you 1.0135 shares as per Akebia Ther share price of $1.48 per share as on May 4, 2026 at 7:36 pm IST.

    What is the minimum amount required to buy Akebia Ther Stock (AKBA) from India?

    Indian investors can start investing in Akebia Ther (AKBA) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹950.67 in Akebia Ther stock (as per the Rupee-Dollar exchange rate as on ). Based on Akebia Ther share’s latest price of $1.48 as on May 4, 2026 at 7:36 pm IST, you will get 6.7568 shares of Akebia Ther. Learn more about fractional shares .

    What are the returns that Akebia Ther has given to Indian investors in the last 5 years?

    Akebia Ther stock has given -52.7% share price returns and 28.57% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?